Assessment of the transport management systems for National Acquired Immunodeficiency Syndrome (AIDS) Council of Zimbabwe Global Fund Round 8 grant sub-recipients and implementing partners, 2014.

Introduction: during a Global Fund sub-sub recipients (SSRs) and implementing partners (IPs) review meeting for quarter 14 held in September 2013, several reports on mismanagement of vehicles were reported. We were then prompted to assess the transport management systems for the SSRs and IPs.

Methods: we conducted a descriptive cross-sectional study.

Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.

Setting: Zimbabwe.

Objective: To investigate the determinants of multidrug-resistant tuberculosis (MDR-TB) among previously treated TB patients.

Design: A 1:3 case-control study with bivariate analysis and logistic regression.

Factors associated with contracting malaria in Ward 29 of Shamva District, Zimbabwe, 2014.

Background: Malaria cases at Wadzanayi Clinic in Shamva District, Zimbabwe, increased drastically, surpassing the epidemic threshold, in week four of December 2013. This rise was sustained, which necessitated an investigation of the outbreak.

Objectives: To identify risk factors and system weaknesses to improve epidemic preparedness and response.

Foodborne illness among factory workers, Gweru, Zimbabwe, 2012: a retrospective cohort study.

Background: On the 20th September 2012 the Gweru district medical officer (DMO) reported a sudden increase in the number of factory workers complaining of symptoms suggestive of gastrointestinal illness. We conducted a retrospective cohort study to determine factors associated with illness among factory workers.

Methods: A retrospective cohort study was conducted from September to October 2012 among 98 randomly selected factory workers.

Delayed initiation of anti-retroviral therapy in TB/HIV co-infected patients, Sanyati District, Zimbabwe, 2011-2012.

Introduction: Tuberculosis (TB) remains a public health problem and is driven by HIV. Recent studies indicate that anti-retroviral therapy (ART) initiated during the first two months of anti-TB treatment (ATT) reduces risk of HIV morbidity and mortality. In Sanyati district, 14% of TB/HIV co-infected patients were initiated on ART during TB treatment, in 2010.